To the best of our knowledge, the roles of CD24, CD44 and EpCAM in NPC tumourigenesis have not been evaluated within the same cell populations in cell lines or patient-derived xenografts (PDXs). The gene discussed is CD24; the disease is nasopharyngeal carcinoma.